Untargeted Metabolomic Analysis and Chemometrics to Identify Potential Marker Compounds for the Chemical Differentiation of Panax ginseng, P. quinquefolius, P. notoginseng, P. japonicus, and P. japonicus var. major
Molecules · 2023
DOI: 10.3390/molecules28062745 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Ruifeng Ji und 5 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700,…. Hauptthemen laut MEDLINE: Panax, Ginsenosides, Saponins. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Fundamental Research Funds for the Central public welfare research institutes, Fundamental Research Funds for the Central Public Welfare Research Institute.
Abstract (Originalsprache)
The Panax L. genus is well-known for many positive physiological effects on humans, with major species including P. ginseng, P. quinquefolius, P. notoginseng, P. japonicus, and P. japonicus var. major, the first three of which are globally popular. The combination of UPLC-QTOF-MS and chemometrics were developed to profile “identification markers” enabling their differentiation. The establishment of reliable biomarkers that embody the intrinsic metabolites differentiating species within the same genus is a key in the modernization of traditional Chinese medicine. In this work, the metabolomic differences among these five species were shown, which is critical to ensure their appropriate use. Consequently, 49 compounds were characterized, including 38 identified robust biomarkers, which were mainly composed of saponins and contained small amounts of amino acids and fatty acids. VIP (projection variable importance) was used to identify these five kinds of ginseng. In conclusion, by illustrating the similarities and differences between the five species of ginseng with the use of an integrated strategy of combining UPLC-QTOF-MS and multivariate analysis, we provided a more efficient and more intelligent manner for explaining how the species differ and how their secondary metabolites affect this difference. The most important biomarkers that distinguished the five species included Notoginsenoside-R1, Majonoside R1, Vinaginsenoside R14, Ginsenoside-Rf, and Ginsenoside-Rd.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Dao-di Herbs, National Resource Center for Chinese Materia Medica, China Academy of Chinese Medical Sciences, Beijing 100700, China.
- School of Chinese Materia Medica, Guangdong Pharmaceutical University, Guangzhou 510006, China.
Förderung
- the Fundamental Research Funds for the Central public welfare research institutes
- Fundamental Research Funds for the Central Public Welfare Research Institute
Zitieren
APA
Ji, R., Garran, T. A., Luo, Y., Cheng, M., Ren, M., & Zhou, X. (2023). Untargeted Metabolomic Analysis and Chemometrics to Identify Potential Marker Compounds for the Chemical Differentiation of Panax ginseng, P. quinquefolius, P. notoginseng, P. japonicus, and P. japonicus var. major. Molecules. https://doi.org/10.3390/molecules28062745
Vancouver
Ji R, Garran TA, Luo Y, Cheng M, Ren M, Zhou X. Untargeted Metabolomic Analysis and Chemometrics to Identify Potential Marker Compounds for the Chemical Differentiation of Panax ginseng, P. quinquefolius, P. notoginseng, P. japonicus, and P. japonicus var. major. Molecules. 2023. doi:10.3390/molecules28062745
BibTeX
@article{Ji2023,
author = {Ji, Ruifeng and Garran, Thomas Avery and Luo, Yilu and Cheng, Meng and Ren, Mengyue and Zhou, Xiuteng},
title = {Untargeted Metabolomic Analysis and Chemometrics to Identify Potential Marker Compounds for the Chemical Differentiation of Panax ginseng, P. quinquefolius, P. notoginseng, P. japonicus, and P. japonicus var. major},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28062745}
}
EUVIMED